Aglaia Oncology Funds and Sinzer – Grant Thornton Launch Dedicated Life Sciences Impact Measuring and Reporting Suite

Dutch life sciences investor Aglaia Oncology Funds, today officially launches its ‘Life Sciences Impact Suite’, a groundbreaking tool enabling measurement and reporting of the social impact realized by investments, alongside financial performance. The suite has been developed in collaboration with consultancy firm Sinzer – Grant Thornton, as a means to accelerate the impact movement and to challenge the Fund industry to demonstrate value beyond financial profits.

Please to read the entire article.

You must be logged in to post a comment Login